Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Take heart, it’s all good news

31.03.2005


New evidence uncovered by researchers in Tayside and Bristol has shown wider benefits of cholesterol lowering drugs for large sections of the public, including women and the elderly.

Researchers have told us for years that cholesterol lowering drugs that lower blood fat levels provide large benefits to those who participated in clinical trails. However, the effects of these drugs were only really applicable to the sorts of carefully selected patients who actually participated in those trials.

The new evidence now available from a combined Tayside and Bristol research project, published this week in the British Medical Journal, shows that these drugs provide benefits of at least an equal level of benefit to patients groups who were excluded from the clinical trial - the old, the very old, women and those who are unfortunate enough to suffer from a number of other pre-existing diseases. This is really good news for those patients because it has often been found that when taken in general use rather than in clinical trials, medicines do not seem to work as well. This can be because the people in the trials have been selected to be those that will benefit most or those that will have the fewest side effects.



Professor Tom MacDonald, of the University of Dundee, the lead author of the research said “The results of this study are very important as we know now that all patients get similar benefits to those who were in the original studies. It is also good news for the research technique of studying routinely collected data (in an anonymous way of course) of many NHS patients and importantly using quality NHS data as well as being able to bring together data from a range of NHS sources. Such research has important implications in ensuring a good risk/benefit ratio for all medicines.”

The study looked at the data of nearly 5000 patients who were discharged from hospital following a heart attack over an 8 year period. The researchers checked to see the level of cardiovascular outcomes or deaths occurring in these patients and whether they had been treated with statin (the name for a particular type of drug class that lowers cholesterol). Those treated with statins had lower rates of cardiovascular outcomes and death compared to those not treated and the level of benefit were similar across all patient groups. Additionally this research study included a far greater proportion of women and showed they also had good results.

This research is part of an on-going series of projects being undertaken by university researchers in conjunction with the NHS in Tayside that uses advanced methods to develop anonymous clinical information. This ensures that the researchers can make the maximum use of such information whilst ensuring confidentiality. Such research helps to ensure that the treatments available on the NHS have the right balance of benefit and risk.

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk/pressreleases/prmar05/heart.html

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>